Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
Completed
- Conditions
- Cardiac Arrest
- Registration Number
- NCT02247947
- Lead Sponsor
- Universitätsklinikum Köln
- Brief Summary
Proteomics is used to identify prognostic markers after CPR. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.
- Detailed Description
Proteomics is used to identify prognostic markers after CPR, i.e. altered proteins on a 2G-gel. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- cardiac arrest
Exclusion Criteria
- trauma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method death at day 20 day 20
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What prognostic markers does proteomics identify in post-CPR neurological outcomes for cardiac arrest patients?
How do protein alterations on 2G-gels correlate with neurological recovery after cardiac arrest in observational studies?
What molecular pathways are affected by cardiac arrest and CPR that influence brain recovery prognosis?
Are there specific protein biomarkers that can predict adverse neurological events following CPR in clinical trials?
How does proteomic analysis of post-CPR patients compare to traditional biomarkers in predicting long-term neurological outcomes?
Trial Locations
- Locations (1)
University Hospital of Cologne
🇩🇪Cologne, NRW, Germany
University Hospital of Cologne🇩🇪Cologne, NRW, Germany